Guardant Health
GH
#1003
Rank
A$34.29 B
Marketcap
A$255.55
Share price
1.75%
Change (1 day)
168.66%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): A-$5.14

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$5.02. In 2025 the company made an earnings per share (EPS) of A-$4.76 an increase over its 2024 EPS that were of A-$5.12.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.148.09%
2025A-$4.76-7.02%
2024A-$5.12-16.82%
2023A-$6.15-33.13%
2022A-$9.2060%
2021A-$5.7555.04%
2020A-$3.71207.14%
2019A-$1.21-19.81%
2018A-$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$0.05171-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.52-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA